Preferred Label : Noonan syndrome 1;
Symbol : NS1;
CISMeF acronym : NS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Noonan syndrome; Male turner syndrome; Female pseudo-turner syndrome; Turner phenotype with normal karyotype;
Included titles and symbols : Pterygium colli syndrome;
Description : Noonan syndrome (NS) is an autosomal dominant disorder characterized by short stature,
facial dysmorphism, and a wide spectrum of congenital heart defects. The distinctive
facial features consist of a broad forehead, hypertelorism, downslanting palpebral
fissures, a high-arched palate, and low-set, posteriorly rotated ears. Cardiac involvement
is present in up to 90% of patients. Pulmonic stenosis and hypertrophic cardiomyopathy
are the most common forms of cardiac disease, but a variety of other lesions are also
observed. Additional relatively frequent features include multiple skeletal defects
(chest and spine deformities), webbed neck, mental retardation, cryptorchidism, and
bleeding diathesis (summary by Tartaglia et al., 2002). - Genetic Heterogeneity of
Noonan Syndrome See also NS3 (609942), caused by mutation in the KRAS gene (190070);
NS4 (610733), caused by mutation in the SOS1 gene (182530); NS5 (611553), caused by
mutation in the RAF1 gene (164760); NS6 (613224), caused by mutation in the NRAS gene
(164790); NS7 (613706), caused by mutation in the BRAF gene (164757); and NS8 (615355),
caused by mutation in the RIT1 gene (609591). See also NS2 (605275) for a possible
autosomal recessive form of NS; Noonan syndrome-like disorder with loose anagen hair
(NSLH; 607721), caused by mutation in the SHOC2 gene (602775); and Noonan syndrome-like
disorder with or without juvenile myelomonocytic leukemia (NSLL; 613563), caused by
mutation in the CBL gene (165360). Mutations in the neurofibromin gene (NF1; 613113),
which is the site of mutations causing classic neurofibromatosis type I (NF1; 162200),
have been found in neurofibromatosis-Noonan syndrome (NFNS; 601321).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the protein tyrosine phosphatase, nonreceptor-type, 11 gene
(PTPN11, 176876.0001);
Neoplasia : Malignant schwannoma; Multiple giant cell granulomas (bones, joints, soft tissues);
Laboratory abnormalities : Partial deficiency of factor XIII(C); Partial deficiency of factor XII(C); Partial deficiency of factor XI(C); Thrombocytopenia;
Prefixed ID : #163950;
Origin ID : 163950;
UMLS CUI : C4551602;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT